{
    "organizations": [],
    "uuid": "ff0dcbd031479f77d91ac80f4f2d8ae53d9c8a03",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/us-health-ebola-zmapp/who-expects-to-get-approval-to-use-zmapp-ebola-drug-in-congo-idUSKCN1IJ20K",
    "ord_in_thread": 0,
    "title": "WHO expects to get approval to use ZMapp Ebola drug in Congo",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "GENEVA (Reuters) - The World Health Organization is discussing with Democratic Republic of Congo whether the government will give approval for the use of Mapp Biopharmaceutical’s experimental ZMapp treatment for Ebola, a senior WHO official said on Friday.\n“We believe it’s likely in the coming days,” WHO’s Deputy Director-General of Emergency Preparedness and Response Peter Salama told a news conference in Geneva.\nReporting by Tom Miles and Kate Kelland; Editing by Catherine Evans\n ",
    "published": "2018-05-18T23:16:00.000+03:00",
    "crawled": "2018-05-19T15:13:02.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "geneva",
        "reuters",
        "world",
        "health",
        "organization",
        "discussing",
        "democratic",
        "republic",
        "congo",
        "whether",
        "government",
        "give",
        "approval",
        "use",
        "mapp",
        "biopharmaceutical",
        "experimental",
        "zmapp",
        "treatment",
        "ebola",
        "senior",
        "official",
        "said",
        "friday",
        "believe",
        "likely",
        "coming",
        "day",
        "deputy",
        "emergency",
        "preparedness",
        "response",
        "peter",
        "salama",
        "told",
        "news",
        "conference",
        "geneva",
        "reporting",
        "tom",
        "mile",
        "kate",
        "kelland",
        "editing",
        "catherine",
        "evans"
    ]
}